Sethera Therapeutics
Business Services · Utah, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
48 S Rio Grande St, Salt Lake City, Utah...Website
www.setheratx.comRevenue
<$5 MillionIndustry
About Sethera Therapeutics
Sethera Therapeutics Org Chart
Is Sethera Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Sethera Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sethera Therapeutics launches new products
Click to see if Sethera Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Sethera Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Sethera Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Sethera Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Sethera Therapeutics
Sethera Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Sethera Therapeutics
Find more new buyers
Company Profile Activity
Activity Insights
Sethera Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sethera Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sethera Therapeutics.
Sethera Therapeutics News & Media
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sethera Therapeutics
Sethera Therapeutics is pioneering peptide-based drug development through its innovative enzymatic cross-linking technology, which facilitates the synthesis of stable polymacrocyclic peptides. Their platform is designed to engage multiple biological targets simultaneously, enhancing precision in therapeutic design and enabling the modulation of com... Read More